Keisuke Yamamoto

发表

Creation of an α-mannosynthase from a broad glycosidase scaffold.

B. G. Davis, Keisuke Yamamoto, 2012, Angewandte Chemie.

5a-Carba-β-D-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.

Motohiro Kato, M. Ohmori, N. Shimma, 2011, Bioorganic & medicinal chemistry.

Exploration of a new type of antimalarial compounds based on febrifugine.

M. Matsumoto, H. Kikuchi, Y. Oshima, 2006, Journal of medicinal chemistry.

Metabolites of febrifugine and its synthetic analogue by mouse liver S9 and their antimalarial activity against Plasmodium malaria parasite.

Hye-Sook Kim, Y. Wataya, H. Kikuchi, 2003, Journal of medicinal chemistry.

Utility of boron clusters for drug design. Relation between estrogen receptor binding affinity and hydrophobicity of phenols bearing various types of carboranyl groups.

H. Kagechika, Y. Endo, Keisuke Yamamoto, 2003, Bioorganic & medicinal chemistry letters.

An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling.

B. G. Davis, M. Crispin, D. Harvey, 2012, Journal of the American Chemical Society.

Optimal Synthetic Glycosylation of a Therapeutic Antibody

S. Mohammed, C. Robinson, J. Benesch, 2016, Angewandte Chemie.

Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.

M. Ohmori, Takamitsu Kobayashi, Tsutomu Sato, 2012, Journal of medicinal chemistry.

Development of a novel class of peroxisome proliferator-activated receptor (PPAR) gamma ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedione scaffold.

S. Shuto, T. Tamura, T. Uemori, 2019, Bioorganic & medicinal chemistry.

Development of Dihydrodibenzooxepine Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Ligands of a Novel Binding Mode as Anticancer Agents: Effective Mimicry of Chiral Structures by Olefinic E/ Z-Isomers.

S. Shuto, T. Tamura, J. Saito, 2018, Journal of medicinal chemistry.

C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.

M. Ohmori, N. Shimma, Takamitsu Kobayashi, 2012, Bioorganic & medicinal chemistry.

Optimal Synthetic Glycosylation of a Therapeutic Antibody

S. Mohammed, C. Robinson, J. Benesch, 2016, Angewandte Chemie.